IHH Healthcare

SINGAPORE (June 12): Given the hit to medical tourism due to measures to curb the spread of Covid-19, hospital operators are likely to be more severely impacted in 2Q, according to CGS-CIMB Research.

Glove manufacturers and healthcare stocks lead the gainers on Tuesday, as the outbreak of the coronavirus spread to 14 countries, including Singapore.

SINGAPORE (20 Dec) : Eight in 10 medical practitioners say Singapore’s healthcare system should focus more on disease prevention as Singaporeans live longer and are more likely to contract a chronic illness at an earlier age. Moreover, nearly half or 49

SINGAPORE (Nov 29): IHH Healthcare posted earnings of RM236.3 million ($77.3 million) for 3QFY2019 ended September, reversing from losses of RM104.1 million a year ago.

SINGAPORE (Sept 25): The ongoing haze has little impact on healthcare providers in terms of revenue or share price, but prolonged haze conditions showed an increase in admissions to private hospitals, an analysis by CGS-CIMB Research has found.

SINGAPORE (Sept 17): IHH Healthcare is seeking to strengthen its position in Malaysia with the proposed acquisition of entire issued share capital of Prince Court Medical Centre for RM 1.02 billion ($336 million).

SINGAPORE (June 11): CGS-CIMB Research says China could be the “cure” for anaemic local growth among Singapore-listed healthcare providers, with a total healthcare market size that is some 46 times larger.

SINGAPORE (May 31): UOB Kay Hian is maintaining “buy” on IHH Healthcare with a target price of RM6.30 ($2.07), which implies 32.8 times 2020F P/E – well below its historical five-year 12 month forward P/E of 57 times based on the stock’s performan

SINGAPORE (Apr 12): Towards the end of July 2012, at a meeting with bankers and fund managers in the run-up to IHH Healthcare’s IPO, an executive of a financial institution asked what was so special about the healthcare provider. “If we throw a few bi

SINGAPORE (Nov 30): Analysts say IHH Healthcare’s 3Q18 headline loss of RM104 million ($34 million) did not come as a surprise, given the 30% q-o-q depreciation of the Turkish lira versus the US dollar.